{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T04:45:32Z","timestamp":1780980332790,"version":"3.54.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.parkreldis.2011.04.007","type":"journal-article","created":{"date-parts":[[2011,5,6]],"date-time":"2011-05-06T16:46:23Z","timestamp":1304700383000},"page":"464-469","source":"Crossref","is-referenced-by-count":7,"title":["Ongoing challenges to finding people with Parkinson\u2019s disease for epidemiological studies: A comparison of population-level case ascertainment methods"],"prefix":"10.1016","volume":"17","author":[{"given":"M. Anne","family":"Harris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieke","family":"Koehoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay","family":"Teschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2011.04.007_bib1","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0895-4356(96)00003-0","article-title":"Age-standardized incidence and prevalence of Parkinson\u2019s disease in a Swedish community","volume":"49","author":"Fall","year":"1996","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.parkreldis.2011.04.007_bib2","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/mds.870130305","article-title":"Prevalence of Parkinson\u2019s disease in Northwestern Italy: comparison of tracer methodology and clinical ascertainment of cases","volume":"13","author":"Chio","year":"1998","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2011.04.007_bib3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1353-8020(02)00093-7","article-title":"The prevalence of Parkinson\u2019s disease in British Columbia, Canada, estimated by using drug tracer methodology","volume":"9","author":"Lai","year":"2003","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2011.04.007_bib4","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ana.10028","article-title":"Cigarette smoking and the incidence of Parkinson\u2019s disease in two prospective studies","volume":"50","author":"Hernan","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2011.04.007_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/bmj.321.7252.21","article-title":"Cross sectional prevalence survey of idiopathic Parkinson\u2019s disease and Parkinsonism in London","volume":"321","author":"Schrag","year":"2000","journal-title":"BMJ (Clin Res Ed)"},{"key":"10.1016\/j.parkreldis.2011.04.007_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1600-0404.2004.00348.x","article-title":"Prevalence of Parkinson\u2019s disease in Sydney","volume":"111","author":"Chan","year":"2005","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.parkreldis.2011.04.007_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/mds.22324","article-title":"Essential tremor might be less frequent than Parkinson\u2019s disease in North Israel Arab villages","volume":"24","author":"Glik","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2011.04.007_bib8","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1001\/archneur.1985.04060070045013","article-title":"A\u00a0prevalence survey of Parkinson\u2019s disease and other movement disorders in the People\u2019s Republic of China","volume":"42","author":"Li","year":"1985","journal-title":"Arch Neurol"},{"key":"10.1016\/j.parkreldis.2011.04.007_bib9","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/mds.20907","article-title":"Use of antiparkinsonian drugs in Denmark: results from a nationwide pharmacoepidemiological study","volume":"21","author":"Brandt-Christensen","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2011.04.007_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archneur.56.1.33","article-title":"Diagnostic criteria for Parkinson disease","volume":"56","author":"Gelb","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.parkreldis.2011.04.007_bib11","series-title":"Definitions, data sources and methods","author":"Statistics Canada","year":"2007"},{"key":"10.1016\/j.parkreldis.2011.04.007_bib12","unstructured":"Statistics Canada \u2013 Health Statistics Division. Quality measures, Canadian Community Health Survey (CCHS) (Survey numbers 3226 and 5015) 2003. URL: http:\/\/www.statcan.gc.ca\/imdb-bmdi\/document\/3226_D9_T9_V1-eng.pdf [accessed 14.08.2010]."},{"key":"10.1016\/j.parkreldis.2011.04.007_bib13","unstructured":"Morgan SG, Cunningham C, Hanley G, Mooney D. The British Columbia Rx Atlas. 2nd ed. University of British Columbia Centre for Health Services and Policy Research. 2009. URL: http:\/\/www.chspr.ubc.ca\/rxatlas\/bc [accessed 26.04.2011]."},{"key":"10.1016\/j.parkreldis.2011.04.007_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2307\/2685469","article-title":"Approximate is better than \u201cexact\u201d for interval estimation of binomial proportions","volume":"52","author":"Agresti","year":"1998","journal-title":"Am Stat"},{"key":"10.1016\/j.parkreldis.2011.04.007_bib15","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.parkreldis.2007.10.010","article-title":"Prescribing pattern of anti-Parkinson drugs in Southern Italy: cross-sectional analysis in the years 2003\u20132005","volume":"14","author":"Trifiro","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2011.04.007_bib16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10072-003-0140-0","article-title":"Use of antiparkinsonian drugs in the Umbria Region","volume":"24","author":"Vanacore","year":"2003","journal-title":"Neurol Sci"},{"key":"10.1016\/j.parkreldis.2011.04.007_bib17","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1368-5031.2005.00426.x","article-title":"Prescribing pattern in Parkinson\u2019s disease: are cost and efficacy overriding factors?","volume":"59","author":"Tan","year":"2005","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.parkreldis.2011.04.007_bib18","first-page":"418","article-title":"A\u00a0community survey of Parkinson\u2019s disease","volume":"141","author":"Snow","year":"1989","journal-title":"CMAJ"},{"key":"10.1016\/j.parkreldis.2011.04.007_bib19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00005650-199802000-00006","article-title":"Validity of diagnostic and drug data in standardized nursing home resident assessments: potential for geriatric pharmacoepidemiology. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology","volume":"36","author":"Gambassi","year":"1998","journal-title":"Med Care"},{"key":"10.1016\/j.parkreldis.2011.04.007_bib20","first-page":"79","article-title":"Validation of a mail questionnaire for parkinsonism in two languages (German and Italian)","volume":"246","author":"Pramstaller","year":"1999","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.parkreldis.2011.04.007_bib21","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0895-4356(98)00017-1","article-title":"Validation of a telephone questionnaire for Parkinson\u2019s disease","volume":"51","author":"Rocca","year":"1998","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.parkreldis.2011.04.007_bib22","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"5","author":"de Lau","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.parkreldis.2011.04.007_bib23","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1089\/jwh.2007.0515","article-title":"Restless legs syndrome in women: a review","volume":"17","author":"Thomas","year":"2008","journal-title":"J\u00a0Womens Health (Larchmt)"},{"key":"10.1016\/j.parkreldis.2011.04.007_bib24","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1002\/mds.21662","article-title":"Levodopa for idiopathic restless legs syndrome: evidence-based review","volume":"22","author":"Conti","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2011.04.007_bib25","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2147\/tcrm.2006.2.4.465","article-title":"Restless leg syndrome: is it a real problem?","volume":"2","author":"Cotter","year":"2006","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.parkreldis.2011.04.007_bib26","first-page":"235","article-title":"Restless legs syndrome","volume":"78","author":"Bayard","year":"2008","journal-title":"Am Fam Phys"},{"key":"10.1016\/j.parkreldis.2011.04.007_bib27","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1517\/14656560902793605","article-title":"Treatment options for restless legs syndrome","volume":"10","author":"Ferini-Strambi","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.parkreldis.2011.04.007_bib28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1353-8020(02)00117-7","article-title":"The increased utilisation of dopamine agonists and the introduction of COMT inhibitors have not reduced levodopa consumption\u2013a nation-wide perspective in Sweden","volume":"9","author":"Askmark","year":"2003","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2011.04.007_bib29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.smrv.2009.03.002","article-title":"Too soon for dopaminergics in the management of restless legs syndrome in children","volume":"13","author":"Harris","year":"2009","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.parkreldis.2011.04.007_bib30","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/mds.10459","article-title":"Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders","volume":"18","author":"Litvan","year":"2003","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2011.04.007_bib31","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.envres.2007.03.002","article-title":"A\u00a0study of the relationships between Parkinson\u2019s disease and markers of traffic-derived and environmental manganese air pollution in two Canadian cities","volume":"104","author":"Finkelstein","year":"2007","journal-title":"Environ Res"},{"key":"10.1016\/j.parkreldis.2011.04.007_bib32","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/art.24193","article-title":"Gout and the risk of Parkinson\u2019s disease: a cohort study","volume":"59","author":"De Vera","year":"2008","journal-title":"Arthritis Rheum"}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802011000988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802011000988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T01:50:59Z","timestamp":1543801859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802011000988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S1353802011000988"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2011.04.007","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}